Showing results (21-30 of 111) with videos related to
Sort By:
Pageof 12
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 15, 2023
Comparative effectiveness of natalizumab on cognition in multiple sclerosis: A cohort studyAli Manouchehrinia, Hanna Larsson, Mohammad Ehsanul Karim, et al.BMC Immunology|July 31, 2013
MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS)Margareta Jernås, Clas Malmeström, Markus Axelsson, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2017
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimodFredrik Piehl, Ingrid Kockum, Mohsen Khademi, et al.Frontiers in Immunology|August 29, 2022
Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosisIgal Rosenstein, Sofia Rasch, Markus Axelsson, et al.Epilepsia|May 19, 2010
Successful epilepsy surgery in a patient with neurosarcoidosisKristina Malmgren, Jan Lycke, Elisabeth Engman, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2013
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosisMarkus Axelsson, Clas Malmeström, Martin Gunnarsson, et al.Multiple Sclerosis and Related Disorders|April 2, 2026
Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosisMagnus Johnsson, Jan Lycke, Lenka Novakova, et al.Journal of Neuroimmunology|April 9, 2008
Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSFClas Malmeström, Jan Lycke, Sara Haghighi, et al.Frontiers in Immunology|February 6, 2023
High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosisIgal Rosenstein, Markus Axelsson, Lenka Novakova, et al.Journal of Neurochemistry|September 3, 2021
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real-world investigationIgal Rosenstein, Sofia Rasch, Markus Axelsson, et al.Pageof 12